The German Pharmacoepidemiological Research Database (GePaRD)
Pharmacoepidemiological research is predominantly conducted on the basis of large routine databases (secondary data). These databases…
Data Protection
Thank you for visiting our website. Confidentiality and data protection are very important to us. We respect the privacy of visitors to our website and want you to feel safe and…
Imprint
The legal owner of this website is the Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, represented by the executive directors Prof. Dr. Iris Pigeot-Kübler, Dr. Frauke…
Marie Skłodowska-Curie Fellowship
The Marie Skłodowska-Curie Actions offer a great option for experienced researchers looking to give their career a boost by working abroad. They offer exciting new…
Promoting Postdocs
With a variety of measures, BIPS is promoting postdocs in their academic careers. For this purpose, a concept was developed which is based on the goals formulated by the Leibniz…
Structured doctoral education
The structured doctoral education consists of three parts: (i) the doctoral seminar "Epidemiology, Prevention Research, and Biometry", (ii) a number of courses on…
Teaching
We cooperate closely with the University of Bremen in the area of Bachelor's and Master's programs. As the professors at BIPS were appointed together with the University of Bremen, BIPS is…
Health Research in the Service of the People
The Leibniz Institute for Prevention Research and Epidemiology - BIPS develops effective strategies for the prevention of chronic, non-communicable…
Upadacitinib (Rinvoq®) is a so-called Januskinase (JAK)-inhibitor which is approved for the treatment of chronic rheumatic diseases such as ulcerative colitis, rheumatic arthritis and atopic…
Our objective is to further the widespread conduct of harmonised data quality assessments in observational health research by extending the cross-disciplinary scope and the methods of our data…
